Marissa Baich
Gil Martin Group – Investor Relations
Replay available
InspireMD Inc. (NSPR) Q2 2025 Earnings Call
InspireMD Inc. (NASDAQ: NSPR) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Marvin Slausman
Chief Executive Officer
Mike Lawless
Chief Financial Officer
Shane Gleason
Chief Commercial Officer
Adam Meador
Analyst, Piper Sandler
Frank Takian
Analyst, Lake Street Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inspiremd Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.114 Good morning and welcome to InspireMD's 00:00:03.114 -- 00:00:07.019 second quarter 2025 earnings conference call. 00:00:07.019 -- 00:00:10.363 Currently, all participants are in a listen-only mode. 00:00:10.363 -- 00:00:13.084 We will be soliciting 00:00:13.947 -- 00:00:17.671 a question and answer session towards the end of today's call. 00:00:17.671 -- 00:00:21.295 As a reminder, this call is being recorded for replay purposes. 00:00:21.295 -- 00:00:25.119 I would now like to turn the call over to Marissa Baich 00:00:25.119 -- 00:00:29.342 from Gil Martin Group for introductory disclosures. 00:00:31.958 -- 00:00:36.162 Thank you for joining us for the InspireMD second quarter 2025 00:00:36.162 -- 00:00:41.387 conference call. Joining us today from InspireMD are Marvin Clausman, Chief 00:00:41.387 -- 00:00:46.132 Executive Officer, and Mike Lawless, Chief Financial Officer. 00:00:46.132 -- 00:00:50.596 During this call, management will be making forward-looking statements, not historical 00:00:50.596 -- 00:00:56.382 facts, which are based upon management's current expectations, beliefs, and projections, 00:00:56.382 -- 00:01:00.967 many of which, by their nature, are inherently uncertain. 00:01:00.967 -- 00:01:06.022 These forward-looking statements involve risks and uncertainties that may cause actual 00:01:06.022 -- 00:01:12.656 results to differ materially from those expressed in such forward-looking statements. 00:01:13.164 -- 00:01:17.657 For more information about these risks please refer to the risk factors described in 00:01:17.657 -- 00:01:23.002 InspireMD's most recently filed periodic reports on Form 10-K 00:01:23.002 -- 00:01:28.908 and Form 10-Q or any other updates in our current reports on Form 8-K 00:01:28.908 -- ...